19 results
6-K
EX-99.2
NTBL
Notable Labs Ltd
2 Jun 22
Notice of Annual General Meeting of Shareholders
5:00pm
tenure at Pitango, Ms. Alon held senior analyst positions with Montgomery Securities from 1981 to 1987, Kidder Peabody & Co. from 1987 to 1993 … . During his tenure at ArQule, he played an important role in ArQule’s transition into a drug discovery and development organization, and in two
6-K
EX-99.1
NTBL
Notable Labs Ltd
5 Oct 21
VBL Therapeutics Announces Appointment of Sam Backenroth as Chief Financial Officer and Establishes Operations in the United States
4:17pm
with cancer and immuno-inflammatory disorders.”
Prior to his tenure at NeuBase, Mr. Backenroth was the CFO of Ohr Pharmaceutical, where he
6-K
EX-99.2
NTBL
Notable Labs Ltd
2 Sep 21
Notice of Annual General Meeting of Shareholders
7:20am
as a general partner in Pitango Venture Capital. Prior to her tenure at Pitango, Ms. Alon held senior positions with Montgomery Securities from 1981 … President, Chief Financial Officer and Treasurer of ArQule Inc. During his tenure at ArQule, he played an important role in ArQule’s transition into a drug
6-K
EX-99.2
3oo2s0zxvo9x2ili0ri
19 Oct 20
Current report (foreign)
4:10pm
6-K
EX-99.2
0vbr1sg0sny
28 May 20
Notice of Annual General Meeting of Shareholders
9:14am
6-K
EX-99.2
fgq0r
1 Nov 19
Current report (foreign)
4:15pm
6-K
EX-99.2
et6on
15 Oct 18
Notice of Annual General Meeting of Shareholders
8:15am
20-F
om4lwf2 7pzdt7rv4zf7
25 Mar 15
Annual report (foreign)
12:00am
424B4
95gvfh1vv8
2 Oct 14
Prospectus supplement with pricing info
12:00am
424B4
ttqafeeg5rmf
1 Aug 14
Prospectus supplement with pricing info
12:00am
F-1/A
EX-10.10
psqqy971u
18 Jul 14
Registration statement (foreign) (amended)
12:00am
- Prev
- 1
- Next